Your session is about to expire
← Back to Search
TriPollar Device for Wrinkles
Study Summary
This trial found that the TriPollar is a safe and effective treatment for facial wrinkles and rhytides.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are able to read, understand and follow instructions of the procedure to be applied.You are able and willing to comply with the treatment and follow-up schedule.I am between 35 and 65 years old and healthy.None. (This is not a valid exclusion criterion for a clinical trial.)
- Group 1: Single arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the clinical trial accept elderly individuals as participants?
"This clinical trial is open to patients within the age range of 35 and 65 years old."
Has recruitment for this trial commenced?
"Clinicaltrials.gov states that the initial posting of this trial was on April 1st 2013, with its most recent update made on August 11th 2013. This study is not currently recruiting participants; however, there are two other trials actively seeking patients for their respective studies."
Do I meet the criteria to be included in this research?
"To be accepted to this experiment, candidates must present signs of skin aging and fall between the ages of 35-65. At the moment, 40 participants need to be enrolled into this research project."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger